| P50 | author | Walter A. Orenstein | Q15429212 |
| | Kylie Ainslie | Q87809398 |
| P2093 | author name string | Meng Shi | |
| | Michael Haber | |
| P2860 | cites work | Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 |
| | Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | Q33554684 |
| | A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting | Q33581365 |
| | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 |
| | A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies. | Q35109002 |
| | Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease | Q36385284 |
| | The test-negative design for estimating influenza vaccine effectiveness | Q38427246 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies | Q38907201 |
| | Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness | Q39429254 |
| | Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. | Q40027900 |
| | Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. | Q42148972 |
| | Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network. | Q42205222 |
| | Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. | Q42227573 |
| | Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. | Q42227574 |
| | The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials | Q42265788 |
| | A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination | Q47162930 |
| | Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 |
| | The case test-negative design for studies of the effectiveness of influenza vaccine. | Q51225150 |
| | Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza | Q56791503 |
| P433 | issue | 52 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza vaccine | Q383260 |
| | bias | Q742736 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 7297-7301 | |
| P577 | publication date | 2017-11-13 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | On the bias of estimates of influenza vaccine effectiveness from test-negative studies | |
| P478 | volume | 35 | |